Cresset Asset Management, LLC Cel Sci Corp Transaction History
Cresset Asset Management, LLC
- $23.6 Billion
- Q2 2024
A detailed history of Cresset Asset Management, LLC transactions in Cel Sci Corp stock. As of the latest transaction made, Cresset Asset Management, LLC holds 17,376 shares of CVM stock, worth $18,418. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,376
Previous 12,376
40.4%
Holding current value
$18,418
Previous $23,000
13.04%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CVM
# of Institutions
71Shares Held
6.16MCall Options Held
16.6KPut Options Held
148K-
Vanguard Group Inc Valley Forge, PA2.41MShares$2.56 Million0.0% of portfolio
-
Black Rock Inc. New York, NY775KShares$821,1860.0% of portfolio
-
Geode Capital Management, LLC Boston, MA559KShares$592,5200.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ448KShares$474,5330.0% of portfolio
-
State Street Corp Boston, MA194KShares$205,1170.0% of portfolio
About CEL SCI CORP
- Ticker CVM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,367,500
- Market Cap $46M
- Description
- CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...